Goldspan Health Review

Goldspan Health in one line: a longevity menu where the price lives on somebody else's site

Goldspan Health sells physician-prescribed semaglutide and tirzepatide inside a wider catalog of peptide protocols spanning eleven categories, all dispensed by licensed 503A and 503B pharmacies. The clinical framing is careful and the pharmacy disclosure is better than most. Two things count against it: you cannot find out what anything costs without leaving the site, and when you do find out, the billing cycle is not the one advertised.

Finding the price is the first obstacle

Nothing on goldspanhealth.com carries a price — not the homepage, not the weight-loss category page, not the product cards. We checked the site's own production JavaScript bundle, which contains the complete protocol catalog, and it holds no price fields at all. Every product instead links out to a third-party storefront, and only there do the numbers appear: $229 a month for semaglutide and $299 for tirzepatide, both for the injection paired with B12.

That is a meaningful transparency gap. A reader comparing providers has to click through to an unfamiliar domain per product just to learn the rate, and there is no pricing page to bookmark or compare. Against a category median of about $169 a month, both figures also sit at the expensive end — Goldspan is not competing on price, and the site's own framing doesn't pretend otherwise.

The month is not a month

The storefront advertises both products with a "/month" suffix. It then explains, further down the same page, that after your first delivery a new supply arrives automatically every 4 weeks. Those are not the same thing. A four-week cycle produces thirteen charges in a year, not twelve — so the real annual cost is one full extra payment above what multiplying the advertised monthly price gives you.

This is a common trap in compounded telehealth and it is rarely stated as plainly as Goldspan states it, so credit where it is due for saying so at all. But the price is still displayed as monthly, and most readers will never scroll to the sentence that corrects it. Budget for thirteen payments a year on either molecule.

• Semaglutide: $229, injection with B12 or glycine
• Tirzepatide: $299, same variant structure
• Real cadence: reships every 4 weeks — 13 charges a year, not 12
• Where the price lives: a third-party storefront, not goldspanhealth.com

What Goldspan does better than most

The pharmacy disclosure is genuinely strong. Goldspan's terms state that all therapies are dispensed by a pharmacy licensed under FDA §503A or §503B, and that the platform connects customers with an independent medical group and those pharmacies. Naming the regulatory class outright is more than most compounded sellers manage, even if no individual facility is named.

The catalog is also unusually thoughtful. Each GLP-1 comes paired with either B12 or glycine — the site frames these as energy versus muscle maintenance — and a separate inflammation category carries microdose semaglutide and tirzepatide protocols, including a sublingual option. For a patient interested in low-dose or non-injectable approaches, that is real optionality. Subscriptions can be paused, delayed or canceled at any time, and shipping is free.

Who should choose Goldspan — and who should walk

Choose it if you want a GLP-1 as part of a broader peptide and longevity protocol rather than as a standalone weight-loss purchase, and if the 503A/503B framing and the microdose options matter to you. The clinical presentation is serious and the flexibility on variants and dosing is better than the category norm.

Skip it if price transparency matters, or if you are cost-sensitive. Having to leave the site to learn the rate is a poor experience, thirteen annual charges makes an already-expensive product more so, and the homepage's "In 50 states" claim sits against terms warning that some therapies are unavailable in certain states.

Bottom line

Goldspan Health is a credible longevity platform with better pharmacy disclosure than most and a genuinely interesting protocol catalog, and we found no FDA warning letters against it. But it publishes no prices on its own site, sends you to a third party to find them, and bills every four weeks under a monthly label. If you want what Goldspan sells, go in knowing you will pay thirteen times a year — and confirm your state before you start.

For a side-by-side, MadeMed ($219/month) and Sunlight ($88/month) are the most comparable options to weigh against Goldspan Health.